News
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...
ABC News’ Dr. Darien Sutton breaks down a new report on GLP-1 weight loss medications and their potential for reducing cancer risk.
Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...
23hon MSNOpinion
Voices: Serena Williams’s GLP-1 partnership marks a disturbing cultural turning point
COMMENT: As a Black woman in a white-dominated sport, Williams experienced unique pressures. Yet to see someone of her ...
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results